Inventor
SWAYZE ERIC E
US186 patents
⚠️ This page may combine multiple inventors who share the name “SWAYZE ERIC E”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ISIS PHARMACEUTICALS INC
21 patentsUS9181549B2Nov 10, 2015
Conjugated antisense compounds and their use
ISIS PHARMACEUTICALS INC69 citations99
US9127276B2Sep 8, 2015
Conjugated antisense compounds and their use
ISIS PHARMACEUTICALS INC136 citations99
US9005906B2Apr 14, 2015
Tetrahydropyran nucleic acid analogs
ISIS PHARMACEUTICALS INC163 citations99
US8030467B2Oct 4, 2011
5′-modified bicyclic nucleic acid analogs
ISIS PHARMACEUTICALS INC327 citations99
US8022193B2Sep 20, 2011
6-modified bicyclic nucleic acid analogs
ISIS PHARMACEUTICALS INC335 citations99
US7750131B2Jul 6, 2010
5′-modified bicyclic nucleic acid analogs
ISIS PHARMACEUTICALS INC202 citations99
US7741457B2Jun 22, 2010
6-modified bicyclic nucleic acid analogs
ISIS PHARMACEUTICALS INC542 citations99
US7696345B2Apr 13, 2010
Polycyclic sugar surrogate-containing oligomeric compounds and compositions for use in gene modulation
ISIS PHARMACEUTICALS INC426 citations99
US7666854B2Feb 23, 2010
Bis-modified bicyclic nucleic acid analogs
ISIS PHARMACEUTICALS INC308 citations99
US7547684B2Jun 16, 2009
5′-modified bicyclic nucleic acid analogs
ISIS PHARMACEUTICALS INC413 citations99
US7399845B2Jul 15, 2008
6-modified bicyclic nucleic acid analogs
ISIS PHARMACEUTICALS INC1,088 citations99
US8796437B2Aug 5, 2014
Tetrahydropyran nucleic acid analogs
ISIS PHARMACEUTICALS INC85 citations98
US7939677B2May 10, 2011
Oligomeric compounds comprising 4′-thionucleosides for use in gene modulation
ISIS PHARMACEUTICALS INC152 citations98
US7875733B2Jan 25, 2011
Oligomeric compounds comprising 4′-thionucleosides for use in gene modulation
ISIS PHARMACEUTICALS INC159 citations98
US7569686B1Aug 4, 2009
Compounds and methods for synthesis of bicyclic nucleic acid analogs
ISIS PHARMACEUTICALS INC501 citations98
US7339051B2Mar 4, 2008
Compositions and methods for the treatment of severe acute respiratory syndrome (SARS)
ISIS PHARMACEUTICALS INC158 citations98
US9181550B2Nov 10, 2015
Compositions and methods for modulating apolipoprotein (a) expression
ISIS PHARMACEUTICALS INC16 citations96
US9163239B2Oct 20, 2015
Compositions and methods for modulating apolipoprotein C-III expression
ISIS PHARMACEUTICALS INC20 citations96
US6335194B1Jan 1, 2002
Antisense modulation of survivin expression
ISIS PHARMACEUTICALS INC69 citations96
US7893039B2Feb 22, 2011
Antibacterial 4,5-substituted aminoglycoside analogs having multiple substituents
ISIS PHARMACEUTICALS INC42 citations95
US9382540B2Jul 5, 2016
Compositions and methods for modulating angiopoietin-like 3 expression
ISIS PHARMACEUTICALS INC13 citations93
IONIS PHARMACEUTICALS INC
10 patentsUS9617540B2Apr 11, 2017
Compounds and methods for modulating gene expression
IONIS PHARMACEUTICALS INC26 citations98
US10493092B2Dec 3, 2019
Antisense compounds
IONIS PHARMACEUTICALS INC28 citations94
US10294477B2May 21, 2019
Compositions and methods for modulating PKK expression
IONIS PHARMACEUTICALS INC25 citations94
US10087210B2Oct 2, 2018
Modified nucleosides, analogs thereof and oligomeric compounds prepared therefrom
IONIS PHARMACEUTICALS INC39 citations94
US9695418B2Jul 4, 2017
Oligomeric compounds comprising bicyclic nucleosides and uses thereof
IONIS PHARMACEUTICALS INC36 citations94
US10844379B2Nov 24, 2020
Conjugated antisense compounds and their use
IONIS PHARMACEUTICALS INC8 citations93
US9957504B2May 1, 2018
Compositions and methods for modulating apolipoprotein (a) expression
IONIS PHARMACEUTICALS INC8 citations93
US9932581B2Apr 3, 2018
Compositions and methods for modulating apolipoprotein C-III expression
IONIS PHARMACEUTICALS INC6 citations93
US9932580B2Apr 3, 2018
Compositions and methods for modulating HBV expression
IONIS PHARMACEUTICALS INC5 citations93
US9914922B2Mar 13, 2018
Oligomeric compounds comprising bicyclic nucleotides and uses thereof
IONIS PHARMACEUTICALS INC14 citations93
SETH PUNIT P
7 patentsUS8546556B2Oct 1, 2013
Carbocyclic alpha-L-bicyclic nucleic acid analogs
SETH PUNIT P249 citations99
US8501805B2Aug 6, 2013
Substituted alpha-L-bicyclic nucleosides
SETH PUNIT P252 citations99
US8278426B2Oct 2, 2012
Carbocyclic bicyclic nucleic acid analogs
SETH PUNIT P323 citations99
US8278283B2Oct 2, 2012
6-disubstituted or unsaturated bicyclic nucleic acid analogs
SETH PUNIT P326 citations99
US8268980B2Sep 18, 2012
5′-modified bicyclic nucleic acid analogs
SETH PUNIT P182 citations99
US8088746B2Jan 3, 2012
Bis-modified bicyclic nucleic acid analogs
SETH PUNIT P175 citations99
US8530640B2Sep 10, 2013
Bicyclic cyclohexitol nucleic acid analogs
SETH PUNIT P229 citations98
SWAYZE ERIC E
5 patentsUS8440803B2May 14, 2013
Tetrahydropyran nucleic acid analogs
SWAYZE ERIC E158 citations99
US8088904B2Jan 3, 2012
Tetrahydropyran nucleic acid analogs
SWAYZE ERIC E164 citations99
US9550988B2Jan 24, 2017
Antisense compounds
SWAYZE ERIC E55 citations98
US8846639B2Sep 30, 2014
Oligomeric compounds comprising bicyclic nucleosides and having reduced toxicity
SWAYZE ERIC E56 citations98
US8642752B2Feb 4, 2014
Modulation of Hepatitis B virus (HBV) expression
SWAYZE ERIC E41 citations98
PRAKASH THAZHA P
2 patentsBHANOT SANJAY
2 patentsMIGAWA MICHAEL T
1 patentALLERSON CHARLES
1 patentESAU CHRISTINE
1 patentShowing the top 50 of 186 patents by PatentIndex Score.